JPH0848678A - Production of tricyclic lactone compound - Google Patents

Production of tricyclic lactone compound

Info

Publication number
JPH0848678A
JPH0848678A JP16307694A JP16307694A JPH0848678A JP H0848678 A JPH0848678 A JP H0848678A JP 16307694 A JP16307694 A JP 16307694A JP 16307694 A JP16307694 A JP 16307694A JP H0848678 A JPH0848678 A JP H0848678A
Authority
JP
Japan
Prior art keywords
lower alkyl
alkyl group
derivative
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP16307694A
Other languages
Japanese (ja)
Inventor
Akira Kanematsu
顯 兼松
Shigeru Nagashima
茂 永島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Priority to JP16307694A priority Critical patent/JPH0848678A/en
Publication of JPH0848678A publication Critical patent/JPH0848678A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To readily obtain a derivative to be an intermediate for important medicines having antihyperlipemic actions such as dihydrocompactin or dihydromevinolin in good yield an octahydronaphthalene derivative as a starting substance. CONSTITUTION:This method for producing a tricyclic lactone compound of formula VI [R<1> is a (aryl)lower alkyl; R<2> is a lower alkyl] is to hydroborate an octahydronaphthalene derivative of formula I, then oxidize the resultant compound, provide a cis-decalin derivative of formula II, convert the prepared derivative into an enol silyl ether, then dehydrosilylate the enol silyl ether, afford an enone compound of formula III, subsequently carry out the conjugated addition reaction of the enone compound of formula III, provide a compound of formula IV (R<6> is a lower alkyl), then epimerize the prepared compound of formula IV with a base, afford a trans-decalin derivative, convert the trans- decalin derivative into a hydrazone derivative of formula V (Ts is p- toluenesulfonyl), further convert the resultant derivative into a tetrahydronaphthalene derivative by the actions of a strong base and subsequently carry out the deacetalization and oxidation.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明に係る製造法及び製造中間
体は、抗高脂血症作用を有するジヒドロコンパクチン、
ジヒドロメビノリン等の鍵製造中間体の製造法及び製造
中間体として重要であり医薬の分野で有用である。
BACKGROUND OF THE INVENTION The production method and the production intermediate according to the present invention are dihydrocompactin having an antihyperlipidemic effect,
It is important as a production method and an intermediate for producing key intermediates such as dihydromevinolin and is useful in the field of medicine.

【0002】[0002]

【従来の技術】請求項1の一般式[X]において、R2
及びR6がメチル基である化合物は、抗高脂血症作用を
有するジヒドロコンパクチン、ジヒドロメビノリン等の
製造中間体として有用であり、従来いくつかの合成法が
報告されている[ステファン・ハネシアン(Steph
an Hanessian)等、ジャーナル・オブ・ジ
・オーガニック・ケミストリー(J.Org.Che
m.,)55巻 5766頁(1990年)等参照]。
2. Description of the Related Art In the general formula [X] of claim 1, R 2
And compounds in which R 6 is a methyl group are useful as intermediates for the production of dihydrocompactin, dihydromevinorin and the like having antihyperlipidemic activity, and several synthetic methods have been reported in the past [Stephan-Hanesian (Steph
an Hannesian) et al., Journal of the Organic Chemistry (J. Org. Che
m. ,) 55, 5766 (1990), etc.].

【0003】[0003]

【発明が解決しようとする課題】しかしながらこれらの
合成法は出発原料より多段の工程を要し、その通算収率
も低いため、実用的製造法の創製が強く望まれている。
However, since these synthetic methods require multiple steps than starting materials and the total yield is low, it is strongly desired to create a practical manufacturing method.

【0004】[0004]

【課題を解決するための手段】本発明者らは重要な医薬
中間体である一般式[X]
DISCLOSURE OF THE INVENTION The inventors of the present invention have the general formula [X] which is an important pharmaceutical intermediate.

【0005】[0005]

【化13】 (式中R2及びR6は同一又は異なって低級アルキル基を
示す)の製造法を鋭意探索した結果、容易に入手可能な
一般式[I]
[Chemical 13] As a result of diligent search for a method for producing (wherein R 2 and R 6 are the same or different and each represents a lower alkyl group), a readily available general formula [I]

【0006】[0006]

【化14】 (式中R1は低級アルキル基又はアリール低級アルキル
基を示し、R2は低級アルキル基を示す)で表される化
合物を出発原料として、短段階で一般式[X]で表され
る化合物を製造する方法を開発し本発明を完成した。
Embedded image (Wherein R 1 represents a lower alkyl group or an aryl lower alkyl group, and R 2 represents a lower alkyl group) is used as a starting material to produce a compound represented by the general formula [X] in a short step. The manufacturing method was developed and the present invention was completed.

【0007】次に本明細書において用いる用語の定義を
説明する。
Next, the definitions of terms used in this specification will be explained.

【0008】「低級アルキル基」とは炭素数1〜6の直
鎖状又は分枝状のアルキル基を意味し、例えばメチル
基、エチル基、プロピル基、イソプロピル基、ブチル
基、イソブチル基、sec−ブチル基、tert−ブチ
ル基、ペンチル基、イソペンチル基、ネオペンチル基、
ヘキシル基、イソヘキシル基等が挙げられる。
The "lower alkyl group" means a linear or branched alkyl group having 1 to 6 carbon atoms, for example, methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, sec. -Butyl group, tert-butyl group, pentyl group, isopentyl group, neopentyl group,
Examples thereof include a hexyl group and an isohexyl group.

【0009】「アリール低級アルキル基」とは炭素数6
〜12のアリール基で置換された前記低級アルキル基を
意味し、例えばベンジル基、フェネチル基、1−ナフチ
ルメチル基、2−ナフチルメチル基、1−ナフチルエチ
ル基、2−ナフチルエチル基等が挙げられる。
The "aryl lower alkyl group" has 6 carbon atoms.
To 12 means the above lower alkyl group substituted with an aryl group, and examples thereof include a benzyl group, a phenethyl group, a 1-naphthylmethyl group, a 2-naphthylmethyl group, a 1-naphthylethyl group and a 2-naphthylethyl group. To be

【0010】「脱離基」とは有機合成化学上通常用いら
れるものを意味し、具体的にはフッ素、塩素、臭素、ヨ
ウ素等のハロゲン原子又はトリフルオロメタンスルホニ
ル基、メタンスルホニル基もしくはp−トルエンスルホ
ニル基等が挙げられる。
The "leaving group" means a group usually used in synthetic organic chemistry, specifically, a halogen atom such as fluorine, chlorine, bromine, iodine or a trifluoromethanesulfonyl group, methanesulfonyl group or p-toluene. Examples thereof include a sulfonyl group.

【0011】次に本明細書において用いる略号を説明す
る。 9−BBN 9−ボラビシクロ[3.3.1]ノナン DBU 1,5−ジアザビシクロ[4.3.0]ノナ −5−エン DBN 1,8−ジアザビシクロ[5.4.0]ウン デカ−7−エン DME 1,2−ジメトキシエタン DMSO ジメチルスルフォキシド LDA リチウムジイソプロピルアミド LCIA リチウムシクロヘキシルイソプロピルアミド LHMDS リチウムヘキサメチルジシラザン KHMDS カリウムヘキサメチルジシラザン PCC ピリジニウムクロロクロメート PDC ピリジニウムジクロメート THF テトラヒドロフラン Ts p−トルエンスルホニル基 次いで本発明に係る製造法について具体的に説明する。
Next, the abbreviations used in this specification will be described. 9-BBN 9-borabicyclo [3.3.1] nonane DBU 1,5-diazabicyclo [4.3.0] non-5-ene DBN 1,8-diazabicyclo [5.4.0] undec-7- Ene DME 1,2-dimethoxyethane DMSO dimethyl sulfoxide LDA lithium diisopropylamide LCIA lithium cyclohexylisopropylamide LHMDS lithium hexamethyldisilazane KHMDS potassium hexamethyldisilazane PCC pyridinium chlorochromate PDC pyridinium dichromate THF tetrahydrofuran Ts p-toluenesulfonyl group Next, the manufacturing method according to the present invention will be specifically described.

【0012】一般式[I]の化合物から一般式[II]
の化合物への変換は、非対称置換炭素炭素二重結合に対
し、反マルコニコフ的に水酸基を導入する試剤であれ
ば、いずれも用いることができるが、特にボラン又は置
換ボラン、次いで塩基性下に過酸化水素等の過酸化物を
用いるヒドロボレーション反応が好ましく、具体的に
は、−78℃〜室温の温度で、THF、1,4−ジオキ
サン等の不活性溶媒中で[I]に対して0.4〜2当量
のボラン・THF錯体、ボラン・ピリジン錯体もしくは
ボラン・ジメチルスルフィド錯体又は1〜3当量のジシ
アミルボラン、テキシルボランもしくは9−BBN等の
置換ボランを加え、1〜48時間反応後、1〜2当量の
水酸化ナトリウム水溶液及び1〜2当量の過酸化水素水
溶液で処理して行うことができる。
From the compound of general formula [I] to general formula [II]
For the conversion of the compound into a compound, any reagent can be used as long as it is an agent that introduces a hydroxyl group into the asymmetrically substituted carbon-carbon double bond in an anti-Marconnikov manner. A hydroboration reaction using a peroxide such as hydrogen oxide is preferable, and specifically, at a temperature of −78 ° C. to room temperature, with respect to [I] in an inert solvent such as THF or 1,4-dioxane. 0.4 to 2 equivalents of borane / THF complex, borane / pyridine complex or borane / dimethyl sulfide complex or 1 to 3 equivalents of substituted borane such as disiamylborane, thexylborane or 9-BBN is added, and after reaction for 1 to 48 hours, 1 It can be performed by treating with ˜2 equivalents of sodium hydroxide aqueous solution and 1 to 2 equivalents of hydrogen peroxide aqueous solution.

【0013】[II]から[III]への変換には、2
級アルコールをケトンに酸化する能力を有する酸化剤で
あればいずれも用いることができるが、特にPCC、P
DC等のクロム酸類による酸化又はスワーン(Swer
n)酸化工程、モファット(Moffat)酸化工程等
のDMSOを酸化剤とする酸化反応が好ましい。
For conversion from [II] to [III], 2
Any oxidizing agent having the ability to oxidize a primary alcohol into a ketone can be used, but especially PCC, P
Oxidation by chromic acids such as DC or Swern (Swer
n) Oxidation reaction using DMSO as an oxidant such as an oxidation step and a Moffat oxidation step is preferable.

【0014】[III]から[IV]への変換は[II
I]をジエチルエーテル、THF等のエーテル系溶媒中
で、−100〜−50℃の温度で、[III]に対し1
〜2当量の強塩基、例えばLDA、LCIA、LHMD
S又はKHMDS等のリチウムアミド類と5分間〜2時
間反応後、1〜2当量のR345SiX(式中R3、R
4及びR5は同一又は異なって低級アルキル基を示すか又
はR3及びR4がフェニル基でR5が低級アルキル基を示
し、Xは脱離基を示す)を加えて行うことができる。
The conversion from [III] to [IV] is [II]
[I] in an ether solvent such as diethyl ether or THF at a temperature of −100 to −50 ° C. to 1 [III].
~ 2 equivalents of a strong base such as LDA, LCIA, LHMD
After reacting with lithium amides such as S or KHMDS for 5 minutes to 2 hours, 1 to 2 equivalents of R 3 R 4 R 5 SiX (in the formula, R 3 , R
4 and R 5 are the same or different and each represents a lower alkyl group, or R 3 and R 4 represent a phenyl group, R 5 represents a lower alkyl group, and X represents a leaving group).

【0015】[IV]から[V]への変換は、例えば三
枝らの方法[ジャーナル・オブ・ジ・オーガニック・ケ
ミストリー(J.Org.Chem.,)43巻101
1頁(1978年)参照]等に従い[V]を0℃〜50
℃好ましくは室温でアセトニトリル等の溶媒中、[I
V]に対して0.2〜2当量、好ましくは0.4〜1当
量の塩化パラジウム又は酢酸パラジウム等の2価のパラ
ジウム化合物及び0.2〜2当量、好ましくは0.4〜
1当量のp−ベンゾキノン等のキノン類の共存下で2〜
30時間反応して行うことができる。
The conversion from [IV] to [V] is carried out, for example, by the method of Saegusa et al. [Journal of the Organic Chemistry (J. Org. Chem.) 43 Vol. 101.
1 page (1978)], etc. [V] at 0 ° C to 50 ° C.
[I], preferably at room temperature in a solvent such as acetonitrile, [I
V] is 0.2 to 2 equivalents, preferably 0.4 to 1 equivalents of a divalent palladium compound such as palladium chloride or palladium acetate, and 0.2 to 2 equivalents, preferably 0.4 to
In the presence of 1 equivalent of quinones such as p-benzoquinone
It can be performed by reacting for 30 hours.

【0016】[V]から[VI]への変換は、−100
℃〜室温で[V]をジエチルエーテル又はTHF等のエ
ーテル系溶媒中で[V]に対し1〜5当量好ましくは1
〜2当量のジ低級アルキル銅リチウム錯体もしくはより
高次の低級アルキル銅リチウム錯体[ビー・リップシュ
ッツ(B.Lipshutz) シンテシス(Synt
hesis)325頁(1987年)等参照]を作用さ
せるか又は1〜3当量の低級アルキルグリニア試薬及び
0.1〜1当量のヨウ化銅を作用させて行うことができ
る。
The conversion from [V] to [VI] is -100
1 to 5 equivalents of [V] with respect to [V] in an ether solvent such as diethyl ether or THF at preferably room temperature to room temperature, preferably 1
˜2 equivalents of di-lower alkyl copper lithium complex or higher lower alkyl copper lithium complex [B. Lipshutz Synthesis (Synt
hesis) p. 325 (1987), etc.] or 1 to 3 equivalents of a lower alkyl Grineer's reagent and 0.1 to 1 equivalent of copper iodide.

【0017】[VI]の[VII]への変換は[VI]
を含水メタノール、含水エタノール等の含水低級アルコ
ール又は含水THFもしくは含水1,4−ジオキサン等
の溶媒中で0℃から溶媒の沸点までの温度で[VI]に
対して1〜10当量好ましくは4〜6当量の炭酸ナトリ
ウム、炭酸カリウム等のアルカリ金属炭酸塩又はDB
U、DBN等の有機塩基類を作用させることによって行
うことができる。
The conversion of [VI] into [VII] is [VI]
In a solvent such as water-containing lower alcohol such as water-containing methanol or water-containing ethanol or water-containing THF or water-containing 1,4-dioxane at a temperature from 0 ° C. to the boiling point of the solvent, 1 to 10 equivalents, preferably 4 to 10 equivalents with respect to [VI]. 6 equivalents of alkali metal carbonate such as sodium carbonate, potassium carbonate or DB
It can be carried out by reacting an organic base such as U or DBN.

【0018】[VII]の[VIII]への変換は、
[VII]をメタノール、エタノール等の低級アルコー
ル溶媒中で0℃から溶媒の沸点までの温度で1〜1.5
当量のp−トルエンスルホニルヒドラジンと10分〜4
間反応させて行うことができる。
The conversion of [VII] into [VIII] is
[VII] in a lower alcohol solvent such as methanol or ethanol at a temperature from 0 ° C. to the boiling point of the solvent for 1 to 1.5.
Equivalent amount of p-toluenesulfonylhydrazine and 10 minutes to 4
It can be carried out by reacting for a while.

【0019】[VIII]の[IX]への変換は、一般
的なバンフォード−スティーブンス(Bamford−
Stevens)反応[ダブリュ・アール・バンフォー
ド(W.R.Bamford)らジャーナル・オブ・ザ
・ケミカル・ソサエティー(J.Chem.So
c.,)4735頁(1952年)及びロバート・エイ
チ・シャピロ(Robert.H.Shapiro)オ
ーガニック・リアクションズ(Organic Rea
ctions)23巻405頁 John Wiley
& Sons等参照]に従い、[VIII]をジエチ
ルエーテル、THF等のエーテル系溶媒中、−100℃
から室温までの温度で[VIII]に対し5〜15当量
のn−ブチルリチウム、sec−ブチルリチウム、te
rt−ブチルリチウム等の強塩基で処理して行うことが
できる。
The conversion of [VIII] into [IX] is performed by a general Banford-Stevens (Bamford-
Stevens) reaction [W.R. Bamford et al. Journal of the Chemical Society (J. Chem. So
c. ,) 4735 (1952) and Robert H. Shapiro Organic Reactions (Organic Rea).
23) 405 John Wiley
& Sons et al.], [VIII] in an ether solvent such as diethyl ether or THF at −100 ° C.
To room temperature from 5 to 15 equivalents of [VIII] n-butyllithium, sec-butyllithium, te
It can be performed by treating with a strong base such as rt-butyllithium.

【0020】[IX]の[X]への変換は、例えば0℃
から室温で無水又は含水アセトン中で[IX]に対し1
〜5当量のジョーンズ試薬等を用いて、おこなうことが
できる。これらを示す。
The conversion of [IX] into [X] is performed at 0 ° C., for example.
To 1 for [IX] in anhydrous or hydrous acetone at room temperature
It can be carried out by using ~ 5 equivalents of Jones reagent or the like. These are shown.

【0021】[0021]

【化15】 [Chemical 15]

【0022】[0022]

【実施例】以下に本発明を実施例を挙げて説明するが本
発明はこれらによって何ら限定されるものではない。
The present invention will be described below with reference to examples, but the present invention is not limited to these examples.

【0023】以下にNMR測定における略号を示す。The abbreviations used in NMR measurement are shown below.

【0024】 s シングレット d ダブレット t トリプレット q カルテット m マルチプレット br ブロード J カップリング定数 Hz ヘルツ 参考例1(2aR,7S,8aS,8bS)−2−メトキシ−7
−メチル−2a,3,4,6,7,8,8a,8b−オ
クタヒドロ−2H−ナフト[1.8−bc]フランの合
兼松らの方法[テトラヘドロン:アシンメトリー(Te
trahedron:Asymmetry)1巻 10
号 743頁(1990年)]等に従い(1S,5S)
−5−メチル−1−プロパルギルオキシ−3−ビニル−
2−シクロヘキセン1.76g(10.0mmol)を
t−ブタノール30mlに溶解し、t−ブトキシカリ
6.16g(55.0mmol)を加えて1時間還流す
る。室温まで冷却しジエチルエーテル50mlを加えた
後、有機層を飽和塩化アンモニウム水溶液、飽和食塩水
で順次洗浄後、有機層を無水硫酸ナトリウムで乾燥して
溶媒を減圧留去後、メタノール60mlに溶解し、
(±)−10−カンファースルホン酸3.0gを加え1
時間撹拌する。反応液にジエチルエーテルを加えた後、
有機層を飽和炭酸水素ナトリウム水溶液、飽和食塩水で
順次洗浄し、有機層を無水硫酸ナトリウムで乾燥後溶媒
を減圧留去し、得られた残渣をシリカゲルカラムクロマ
トグラフィー(ヘキサン:酢酸エチル=10:1)で分
離精製し表題化合物2.06g(収率99%)を無色油
状物質として得る。
S Singlet d Doublet t Triplet q Quartet m Multiplet br Broad J Coupling constant Hz Hertz Reference example 1 (2aR, 7S, 8aS, 8bS) -2-methoxy-7
-Methyl-2a, 3,4,6,7,8,8a, 8b-o
The combination of Kutahydro-2H-naphtho [1.8-bc] furan
Formed Kanematsu et al's method [Tetrahedron: Asymmetry (Te
trahedron: Asymmetry) 1 volume 10
No. 743 (1990)], etc. (1S, 5S)
-5-methyl-1-propargyloxy-3-vinyl-
2.76 g (10.0 mmol) of 2-cyclohexene is dissolved in 30 ml of t-butanol, 6.16 g (55.0 mmol) of t-butoxy potassium is added, and the mixture is refluxed for 1 hour. After cooling to room temperature and adding 50 ml of diethyl ether, the organic layer was washed successively with saturated aqueous ammonium chloride solution and saturated saline solution, the organic layer was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure, and the residue was dissolved in 60 ml of methanol. ,
Add 3.0 g of (±) -10-camphorsulfonic acid and add 1
Stir for hours. After adding diethyl ether to the reaction solution,
The organic layer was washed successively with saturated aqueous sodium hydrogen carbonate solution and saturated brine, the organic layer was dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure. The obtained residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 10: Separation and purification in 1) yields 2.06 g (yield 99%) of the title compound as a colorless oily substance.

【0025】 [α]23 D −52.0°(c=2.5 クロロホル
ム)1 H−NMR(CDCl3,δ,ppm) 0.97(3H,d,J=6.9Hz),1.49−
1.93(6H,m),1.97−2.13(2H,
m),2.25−2.30(1H,m),2.36−
2.43(1H,m),2.51(1H,m),3.3
8(3H,s),4.25(1H,q,J=5.2H
z),4.74(1H,d,J=3.6Hz),5.5
4(1H,m)13 C−NMR(CDCl3,δ,ppm) 20.931(q),21.580(t),21.60
5(t),27.419(d),34.310(t),
39.990(t),41.079(d),44.66
6(d),55.523(q),77.617(d),
107.864(d),123.336(d),13
2.737(s) IR(KBr,cm-1) 2920,1100 高分解能質量スペクトル m/z C13202として 計算値 208.1464 測定値 208.1462 実施例1(2aR,3S,5aR,7S,8aS,8bS)−2
−オキソ−3,7−ジメチル−2a,3,5a,6,
7,8,8a,8b−オクタヒドロ−2H−ナフト−
[1.8−bc]フランの製造 1.(2aR,3s,5aR,7S,8aS,8bS)
−2a,3,4,5,5a,6,7,8,8a,8b−
デカヒドロ−5−ヒドロキシ−7−メチル−2H−ナフ
ト−[1.8−bc]−フランの合成 参考例1で得た(2aR,7S,8aS,8bS)−2
−メトキシ−7−メチル−2a,3,4,6,7,8,
8a,8b−オクタヒドロ−2H−ナフト[1.8−b
c]フラン 4.19g(20.1mmol)を無水T
HF20mlに溶解し、0℃で1.0MボランTHF錯
体THF溶液20.1ml(20.1mmol)を加え
0℃で20時間撹拌する。室温で10%水酸化ナトリウ
ム水溶液20ml及び30%過酸化水素水溶液10ml
を順次加えた後25℃で2時間撹拌する。反応液を酢酸
エチルで抽出し有機層を5%チオ硫酸ナトリウム水溶液
及び飽和食塩水で順次洗浄し、無水硫酸ナトリウムで乾
燥後溶媒を減圧留去し表題化合物を無色油状物質として
得る。このものはさらに精製することなく次の工程に使
用することができる。
[Α] 23 D −52.0 ° (c = 2.5 chloroform) 1 H-NMR (CDCl 3 , δ, ppm) 0.97 (3 H, d, J = 6.9 Hz), 1. 49-
1.93 (6H, m), 1.97-2.13 (2H,
m), 2.25-2.30 (1H, m), 2.36-
2.43 (1H, m), 2.51 (1H, m), 3.3
8 (3H, s), 4.25 (1H, q, J = 5.2H
z), 4.74 (1H, d, J = 3.6Hz), 5.5
4 (1H, m) 13 C-NMR (CDCl 3 , δ, ppm) 20.931 (q), 21.580 (t), 21.60
5 (t), 27.419 (d), 34.310 (t),
39.990 (t), 41.079 (d), 44.66.
6 (d), 55.523 (q), 77.617 (d),
107.864 (d), 123.336 (d), 13
2.737 (s) IR (KBr, cm -1 ) 2920, 1100 High-resolution mass spectrum m / z C 13 H 20 O 2 Calculated value 208.1464 Measured value 208.1462 Example 1 (2aR, 3S, 5aR) , 7S, 8aS, 8bS) -2
-Oxo-3,7-dimethyl-2a, 3,5a, 6
7,8,8a, 8b-Octahydro-2H-naphtho-
Production of [1.8-bc] furan (2aR, 3s, 5aR, 7S, 8aS, 8bS)
-2a, 3,4,5,5a, 6,7,8,8a, 8b-
Synthesis of decahydro-5-hydroxy-7-methyl-2H-naphtho- [1.8-bc] -furan (2aR, 7S, 8aS, 8bS) -2 obtained in Reference Example 1.
-Methoxy-7-methyl-2a, 3,4,6,7,8,
8a, 8b-Octahydro-2H-naphtho [1.8-b
c] 4.19 g (20.1 mmol) of furan was added to anhydrous T
Dissolve in 20 ml of HF, add 20.1 ml (20.1 mmol) of 1.0 M borane THF complex THF solution at 0 ° C., and stir at 0 ° C. for 20 hours. 20 ml of 10% sodium hydroxide aqueous solution and 10 ml of 30% hydrogen peroxide aqueous solution at room temperature
And the mixture is stirred at 25 ° C. for 2 hours. The reaction solution is extracted with ethyl acetate, the organic layer is washed successively with 5% aqueous sodium thiosulfate solution and saturated brine, dried over anhydrous sodium sulfate, and the solvent is evaporated under reduced pressure to give the title compound as a colorless oily substance. This product can be used in the next step without further purification.

【0026】2.(2aR,5aR,7S,8aS,8
bS)−5−オキソ−2a,3,4,5,5a,6,
7,8,8a,8b−デカヒドロ−2−メトキシ−7−
メチル−2H−ナフト−[1.8−bc]フランの製造 前記1.で得た(2aR,3s,5aR,7S,8a
S,8bS)−2a,3,4,5,5a,6,7,8,
8a,8b−デカヒドロ−5−ヒドロキシ−7−メチル
−2H−ナフト−[1.8−bc]−フランの粗生成物
全量の無水塩化メチレン150ml溶液にセライト20
gを加え,0℃でPCC6.47g(30.0mmo
l)を加え2時間撹拌する。ジエチルエーテル100m
lを加え20分間撹拌後フロリジルカラムを通し、溶媒
を減圧留去し得られた残渣をシリカゲルカラムクロマト
グラフィー(ヘキサン:酢酸エチル=2:1)で分離精
製し表題化合物3.565g(通算収率79%)を無色
結晶として得る。
2. (2aR, 5aR, 7S, 8aS, 8
bS) -5-oxo-2a, 3,4,5,5a, 6
7,8,8a, 8b-decahydro-2-methoxy-7-
Production of Methyl-2H-naphtho- [1.8-bc] furan Obtained in (2aR, 3s, 5aR, 7S, 8a
S, 8bS) -2a, 3,4,5,5a, 6,7,8,
The crude product of 8a, 8b-decahydro-5-hydroxy-7-methyl-2H-naphtho- [1.8-bc] -furan was dissolved in 150 ml of anhydrous methylene chloride to a solution of Celite 20.
PCC 6.47g (30.0mmo
l) is added and the mixture is stirred for 2 hours. 100m of diethyl ether
1 was added and stirred for 20 minutes, passed through a Florisil column, the solvent was distilled off under reduced pressure, and the resulting residue was separated and purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1) to give 3.565 g of the title compound (total yield). 79%) as colorless crystals.

【0027】 融点 71.0−71.5℃(ヘキサンより再結晶) [α]24 D −129.1°(c=1.2 クロロホル
ム)1 H−NMR(CDCl3,δ,ppm) 0.87−1.01(1H,m),1.03(3H,
d,J=6.6Hz),1.43−1.64(2H,
m),1.77−2.10(3H,m),2.31−
2.38(2H,m),2.50(1H,dt,J=
2.9Hz,7.7Hz),2.57−2.65(1
H,m),2.80(1H,dt,J=9.2Hz,
7.8Hz),3.34(3H,s),4.25(1
H,dt,J=10.2Hz,7.3Hz),4.79
(1H,s)13 C−NMR(CDCl3,δ,ppm) 22.698(q),23.283(t),24.57
0(d),27.964(t),34.165(t),
35.978(t),38.085(d),42.88
2(d),43.291(d),54.407(q),
77.574(d),109.399(d),213.
299(s) IR(KBr,cm-1) 2950,2860,171
0,1100 質量スペクトル m/z 224(M+,5.4),1
92(68.4),164(81.0),122(10
0) 元素分析値 C13203として 計算値 C,69.61;H,8.99 測定値 C,69.75;H,8.91 3.(2aR,5aR,7S,8aS,8bS)−5−
オキソ−2−メトキシ−7−メチル−2a,5,5a,
6,7,8,8a,8b−オクタヒドロ−2H−ナフト
−[1.8−bc]フランの製造 上記2.で得た(2aR,5aR,7S,8aS,8b
S)−5−オキソ−2a,3,4,5,5a,6,7,
8,8a,8b−デカヒドロ−2−メトキシ−7−メチ
ル−2H−ナフト−[1.8−bc]フラン 2.09
8g(9.4mmol)を無水THF15mlに溶解
し、−78℃でLDA18.8mmolの無水THF1
5ml溶液に滴下する。30分間同温度で撹拌した後ク
ロロトリメチルシラン3.58ml(28.2mmo
l)を急速に加え25℃で2時間撹拌した後、反応液を
ジエチルエーテルで抽出し、有機層を飽和炭酸水素ナト
リウム水溶液及び飽和食塩水で順次洗浄し、無水硫酸ナ
トリウムで乾燥後溶媒を減圧留去しエノールシリルエー
テルを無色油状物質として得る。次いで三枝らの方法
[ジャーナル・オブ・ジ・オーガニック・ケミストリー
(J.Org.Chem.,)43巻1011頁(19
78年)参照]等に従い、酢酸パラジウム2.312g
(10.3mmol)のアセトニトリル40ml溶液を
35℃に保ちながら、エノールシリルエーテルの粗生成
物全量のアセトニトリル20ml溶液を滴下して加え、
35℃で4時間撹拌する。反応液を塩化メチレンで希釈
後セライトのカラムを通し、溶媒を減圧留去し得られた
残渣をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=1:1)で分離精製し表題化合物1.
853g(通算収率89%)を無色結晶として得る。
Melting point 71.0-71.5 ° C. (recrystallized from hexane) [α] 24 D- 129.1 ° (c = 1.2 chloroform) 1 H-NMR (CDCl 3 , δ, ppm) 0. 87-1.01 (1H, m), 1.03 (3H,
d, J = 6.6 Hz), 1.43-1.64 (2H,
m), 1.77-2.10 (3H, m), 2.31-
2.38 (2H, m), 2.50 (1H, dt, J =
2.9 Hz, 7.7 Hz), 2.57-2.65 (1
H, m), 2.80 (1H, dt, J = 9.2 Hz,
7.8 Hz), 3.34 (3 H, s), 4.25 (1
H, dt, J = 10.2 Hz, 7.3 Hz), 4.79
(1H, s) 13 C-NMR (CDCl 3 , δ, ppm) 22.698 (q), 23.283 (t), 24.57
0 (d), 27.964 (t), 34.165 (t),
35.978 (t), 38.085 (d), 42.88
2 (d), 43.291 (d), 54.407 (q),
77.574 (d), 109.399 (d), 213.
299 (s) IR (KBr, cm -1 ) 2950, 2860, 171
0.1100 Mass spectrum m / z 224 (M + , 5.4), 1
92 (68.4), 164 (81.0), 122 (10)
0) Elemental analysis value C 13 H 20 O 3 calculated value C, 69.61; H, 8.99 measured value C, 69.75; H, 8.91 3. (2aR, 5aR, 7S, 8aS, 8bS) -5-
Oxo-2-methoxy-7-methyl-2a, 5,5a,
Preparation of 6,7,8,8a, 8b-octahydro-2H-naphtho- [1.8-bc] furan (2aR, 5aR, 7S, 8aS, 8b
S) -5-oxo-2a, 3,4,5,5a, 6,7,
8,8a, 8b-Decahydro-2-methoxy-7-methyl-2H-naphtho- [1.8-bc] furan 2.09
8 g (9.4 mmol) was dissolved in 15 mL of anhydrous THF, and LDA 18.8 mmol of anhydrous THF1 was dissolved at -78 ° C.
Add dropwise to 5 ml solution. After stirring for 30 minutes at the same temperature, 3.58 ml of chlorotrimethylsilane (28.2 mmo
l) was rapidly added and the mixture was stirred at 25 ° C. for 2 hours, the reaction solution was extracted with diethyl ether, the organic layer was washed successively with saturated aqueous sodium hydrogen carbonate solution and saturated brine, dried over anhydrous sodium sulfate, and the solvent was depressurized. Evaporation yields the enol silyl ether as a colorless oil. Then, the method of Saegusa et al. [Journal of the Organic Chemistry (J. Org. Chem.) 43: 1011 (19
1978)]], etc.
While maintaining a solution of (10.3 mmol) in 40 ml of acetonitrile at 35 ° C., a solution of 20 ml of acetonitrile in total of the crude product of the enol silyl ether was added dropwise.
Stir at 35 ° C. for 4 hours. The reaction mixture was diluted with methylene chloride, passed through a column of Celite, the solvent was evaporated under reduced pressure, and the resulting residue was separated and purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1) to give the title compound 1.
853 g (total yield 89%) is obtained as colorless crystals.

【0028】融点 47.0−47.5℃(石油エーテ
ルより再結晶) [α]25 D−137.6°(c=1.2,クロロホル
ム)1 H−NMR(CDCl3,δ,ppm) 0.91(1H,q,J=11.8Hz),1.06
(3H,d,J=6.7Hz),1.58−1.72
(2H,m),1.82(1H,dt,J=13.4H
z,5.0Hz),2.19(1H,dt,J=12.
8Hz,4.1hz),2.56(1H,ddd,J=
3.4Hz,5.2Hz,8.5Hz),3.00(1
H,q,J=8.3Hz),3.14(1H,dt,J
=8.1Hz,2.9Hz),3.36(3H,s),
4.21(1H,ddd,J=4.7Hz,9.0H
z,11.4Hz),4.88(1H,s),6.06
(1H,dd,J=2.1Hz,10.1Hz),6.
72(1H,dd,J=3.4Hz,10.1Hz)13 C−NMR(CDCl3,δ,ppm) 23.541(q),24.552(d),28.51
9(t),34.819(t),37.233(d),
40.471(d),45.813(d),54.48
7(q),77.758(d),107.235
(d),129.979(d),145.736
(d),199.792(s) IR(KBr,cm-1) 2930,1685,108
5,980 高分解能質量スペクトル m/z (C13183+H +として 計算値 223.1333 測定値 223.1325 元素分析値 C13183として 計算値 C,70.24;H,8.16 測定値 C,70.29;H,8.14 4.(2aR,3S,5aR,7S,8aS,8bS)
−5−オキソ−2a,3,4,5,5a,6,7,8,
8a,8b−デカヒドロ−3,7−ジメチル−−2−メ
トキシ−2H−ナフト−[1.8−bc]フランの合成 ヨウ化銅2.533g(13.3mmol)のジエチル
エーテル20ml懸濁液に0℃で1.0Mメチルリチウ
ムジエチルエーテル溶液26.6ml(26.6mmo
l)を滴下して加えた後、上記3.で得た(2aR,5
aR,7S,8aS,8bS)−5−オキソ−2−メト
キシ−7−メチル−2a,5,5a,6,7,8,8
a,8b−オクタヒドロ−2H−ナフト−[1.8−b
c]フラン1.473g(6.6mmol)のジエチル
エーテル10ml溶液を滴下して加え0℃で2時間撹拌
した後反応液を水に注ぎジエチルエーテルで抽出する。
有機層を飽和塩化アンモニウム水溶液及び飽和塩化ナト
リウム水溶液で洗浄後、無水硫酸ナトリウムで乾燥し溶
媒を減圧留去し得られた残渣をシリカゲルカラムクロマ
トグラフィー(ヘキサン:酢酸エチル=2:1)で分離
精製し表題化合物1.523g(収率96%)を無色結
晶として得る。
Melting point 47.0-47.5 ° C. (petroleum ether
Re-crystallized from le) [α]twenty five D-137.6 ° (c = 1.2, chloroform
)1 H-NMR (CDCl3, Δ, ppm) 0.91 (1H, q, J = 11.8 Hz), 1.06
(3H, d, J = 6.7 Hz), 1.58-1.72
(2H, m), 1.82 (1H, dt, J = 13.4H
z, 5.0 Hz), 2.19 (1H, dt, J = 12.
8 Hz, 4.1 hz), 2.56 (1 H, ddd, J =
3.4 Hz, 5.2 Hz, 8.5 Hz), 3.00 (1
H, q, J = 8.3 Hz), 3.14 (1H, dt, J
= 8.1 Hz, 2.9 Hz), 3.36 (3H, s),
4.21 (1H, ddd, J = 4.7Hz, 9.0H
z, 11.4 Hz), 4.88 (1H, s), 6.06
(1H, dd, J = 2.1Hz, 10.1Hz), 6.
72 (1H, dd, J = 3.4Hz, 10.1Hz)13 C-NMR (CDCl3, Δ, ppm) 23.541 (q), 24.552 (d), 28.51
9 (t), 34.819 (t), 37.233 (d),
40.471 (d), 45.813 (d), 54.48
7 (q), 77.758 (d), 107.235
(D), 129.979 (d), 145.7736
(D), 199.792 (s) IR (KBr, cm-1) 2930, 1685, 108
5,980 High-resolution mass spectrum m / z (C13H18O3+ H )+Calculated value 223.1333 Measured value 223.1325 Elemental analysis value C13H18O3Calculated value C, 70.24; H, 8.16 Measured value C, 70.29; H, 8.14 4. (2aR, 3S, 5aR, 7S, 8aS, 8bS)
-5-oxo-2a, 3,4,5,5a, 6,7,8,
8a, 8b-decahydro-3,7-dimethyl-2-me
Synthesis of Toxy-2H-naphtho- [1.8-bc] furan 2.533 g (13.3 mmol) diethyl iodide copper
To a suspension of 20 ml of ether at 0 ° C, 1.0M methyllithium
26.6 ml (26.6 mmo) of diethyl ether solution
l) was added dropwise, and the above 3. Obtained (2aR, 5
aR, 7S, 8aS, 8bS) -5-oxo-2-meth
Xy-7-methyl-2a, 5,5a, 6,7,8,8
a, 8b-Octahydro-2H-naphtho- [1.8-b
c] 1.473 g (6.6 mmol) of furan diethyl
Add 10 ml of ether dropwise and stir for 2 hours at 0 ° C.
After that, the reaction solution is poured into water and extracted with diethyl ether.
The organic layer was saturated aqueous ammonium chloride and saturated sodium chloride.
After washing with an aqueous solution of sodium, dry it with anhydrous sodium sulfate and dissolve.
The solvent was distilled off under reduced pressure and the resulting residue was purified by silica gel column chromatography.
Separation by chromatography (hexane: ethyl acetate = 2: 1)
Purified and colorless compound (1.523 g, yield 96%) was obtained.
Obtain as crystals.

【0029】融点 60.5−61.0℃(石油エーテ
ルより再結晶) [α]25 D−40.1°(c=1.0,クロロホルム)1 H−NMR(CDCl3,δ,ppm) 0.95−1.09(1H,m),1.06(3H,
d,J=6.3Hz),1.08(3H,d,J=5.
9Hz),1.56−2.12(7H,m),2.37
−2.44(1H,m)2.49−2.57(1H,
m),2.93(1H,q,J=8.7Hz),3.3
7(3H,s),4.20(1H,ddd,J=4.8
Hz,8.7Hz,9.9Hz),4.84(s,1
H)13 C−NMR(CDCl3,δ,ppm) 21.409(q),23.298(q),25.47
0(d),30.272(t),31.527(d),
35.250(t),38.461(d),44.80
1(d),45.786(t),51.628(d),
54.703(q),77.232(d),107.4
91(d),212.918(s) IR(KBr,cm-1) 2920,1700,108
5,1060 質量スペクトル m/z 238(M+,2.2),2
06(50.7),178(47.3),136(10
0) 元素分析値 C14223として 計算値 C,70.55;H,9.30 測定値 C,70.55;H,9.34 5.(2aR,3S,5aS,7S,8aS,8bS)
−5−オキソ−2a,3,4,5,5a,6,7,8,
8a,8b−デカヒドロ−3,7−ジメチル−−2−メ
トキシ−2H−ナフト−[1.8−bc]フランの合成 上記4.で得た(2aR,3S,5aR,7S,8a
S,8bS)−5−オキソ−2a,3,4,5,5a,
6,7,8,8a,8b−デカヒドロ−3,7−ジメチ
ル−2−メトキシ−2H−ナフト−[1.8−bc]フ
ラン228mg(0.96mmol)及び無水炭酸カリ
ウム663mg(4.8mmol)のメタノール10m
l溶液を2時間加熱還流する。室温に冷却後反応液を酢
酸エチル50mlで希釈し、有機層を飽和塩化アンモニ
ウム水溶液及び飽和塩化ナトリウム水溶液で洗浄後、無
水硫酸ナトリウムで乾燥し溶媒を減圧留去し得られた残
渣をシリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=2:1)で分離精製し表題化合物209m
g(収率92%)を無色結晶として得る。
Melting point 60.5-61.0 ° C. (recrystallized from petroleum ether) [α] 25 D -40.1 ° (c = 1.0, chloroform) 1 H-NMR (CDCl 3 , δ, ppm) 0.95-1.09 (1H, m), 1.06 (3H,
d, J = 6.3 Hz), 1.08 (3H, d, J = 5.
9Hz), 1.56-2.12 (7H, m), 2.37
-2.44 (1H, m) 2.49-2.57 (1H,
m), 2.93 (1H, q, J = 8.7 Hz), 3.3
7 (3H, s), 4.20 (1H, ddd, J = 4.8)
Hz, 8.7 Hz, 9.9 Hz), 4.84 (s, 1
H) 13 C-NMR (CDCl 3 , δ, ppm) 21.409 (q), 23.298 (q), 25.47.
0 (d), 30.272 (t), 31.527 (d),
35.250 (t), 38.461 (d), 44.80
1 (d), 45.786 (t), 51.628 (d),
54.703 (q), 77.232 (d), 107.4.
91 (d), 212.918 (s) IR (KBr, cm -1 ) 2920, 1700, 108
5,1060 Mass spectrum m / z 238 (M + , 2.2), 2
06 (50.7), 178 (47.3), 136 (10
0) Calculated value as elemental analysis value C 14 H 22 O 3 C, 70.55; H, 9.30 Measured value C, 70.55; H, 9.34 5. (2aR, 3S, 5aS, 7S, 8aS, 8bS)
-5-oxo-2a, 3,4,5,5a, 6,7,8,
Synthesis of 8a, 8b-decahydro-3,7-dimethyl-2-methoxy-2H-naphtho- [1.8-bc] furan 4. (2aR, 3S, 5aR, 7S, 8a
S, 8bS) -5-oxo-2a, 3,4,5,5a,
6,7,8,8a, 8b-decahydro-3,7-dimethyl-2-methoxy-2H-naphtho- [1.8-bc] furan 228 mg (0.96 mmol) and anhydrous potassium carbonate 663 mg (4.8 mmol). 10m of methanol
The solution is heated to reflux for 2 hours. After cooling to room temperature, the reaction solution was diluted with 50 ml of ethyl acetate, the organic layer was washed with saturated aqueous ammonium chloride solution and saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. Graphography (hexane:
Separated and purified with ethyl acetate = 2: 1) to give 209 m of the title compound.
g (92% yield) is obtained as colorless crystals.

【0030】融点 71.0−72.0℃(石油エーテ
ルより再結晶) [α]26 D+141.7°(c=1.0,クロロホル
ム)1 H−NMR(CDCl3,δ,ppm) 1.03(3H,d,J=6.6Hz),1.10(3
H,d,J=5.3Hz),0.94−1.14(1
H,m),1.42−1.55(2H,m),1.62
−1.76(2H,m),1.83−2.11(4H,
m)2.30−2.57(2H,m),3.39(3
H,s),4.35(1H,q,J=5.9Hz),
4.81(s,1H)13 C−NMR(CDCl3,δ,ppm) 20.525(q),21.560(q),24.72
1(d),28.783(t),29.778(d),
33.423(t),39.718(d),40.01
4(d),45.501(t),53.087(d),
54.862(q),76.396(d),109.9
53(d),213.773(s) IR(KBr,cm-1) 2950,1710,110
0,1060 質量スペクトル m/z 238(M+,2.1),2
06(96.0),178(47.0),136(10
0) 元素分析値 C14223として 計算値 C,70.55;H,9.30 測定値 C,70.46;H,9.27 6.(2aR,3S,5aR,7S,8aS,8bS)
−5−オキソ−2a,3,4,5,5a,6,7,8,
8a,8b−デカヒドロ−3,7−ジメチル−−2−メ
トキシ−2H−ナフト−[1.8−bc]フラン p−
トルエンスルホニルヒドラゾンの合成 上記5.で得た(2aR,3S,5aS,7S,8a
S,8bS)−5−オキソ−2a,3,4,5,5a,
6,7,8,8a,8b−デカヒドロ−3,7−ジメチ
ル−2−メトキシ−2H−ナフト−[1.8−bc]フ
ラン 96mg(0.40mmol)及びp−トルエン
スルホニルヒドラジン89mg(0.48mmol)の
メタノール溶液を2時間加熱還流する。室温に冷却後溶
媒を減圧留去し表題化合物を無色粉末として得る。この
ものは精製することなく次の工程に用いることができ
る。
Melting point 71.0-72.0 ° C. (recrystallized from petroleum ether) [α] 26 D + 141.7 ° (c = 1.0, chloroform) 1 H-NMR (CDCl 3 , δ, ppm) 1 0.03 (3H, d, J = 6.6Hz), 1.10 (3
H, d, J = 5.3 Hz), 0.94-1.14 (1
H, m), 1.42-1.55 (2H, m), 1.62
-1.76 (2H, m), 1.83-2. 11 (4H,
m) 2.30-2.57 (2H, m), 3.39 (3
H, s), 4.35 (1H, q, J = 5.9 Hz),
4.81 (s, 1H) 13 C-NMR (CDCl 3 , δ, ppm) 20.525 (q), 21.560 (q), 24.72
1 (d), 28.783 (t), 29.778 (d),
33.423 (t), 39.718 (d), 40.01
4 (d), 45.501 (t), 53.087 (d),
54.862 (q), 76.396 (d), 109.9.
53 (d), 213.773 (s) IR (KBr, cm -1 ) 2950, 1710, 110
0,1060 mass spectrum m / z 238 (M + , 2.1), 2
06 (96.0), 178 (47.0), 136 (10)
0) Elemental analysis value C 14 H 22 O 3 calculated value C, 70.55; H, 9.30 measured value C, 70.46; H, 9.27 6. (2aR, 3S, 5aR, 7S, 8aS, 8bS)
-5-oxo-2a, 3,4,5,5a, 6,7,8,
8a, 8b-decahydro-3,7-dimethyl-2-methoxy-2H-naphtho- [1.8-bc] furan p-
Synthesis of toluenesulfonylhydrazone 5. Obtained in (2aR, 3S, 5aS, 7S, 8a
S, 8bS) -5-oxo-2a, 3,4,5,5a,
6,7,8,8a, 8b-Decahydro-3,7-dimethyl-2-methoxy-2H-naphtho- [1.8-bc] furan 96 mg (0.40 mmol) and p-toluenesulfonylhydrazine 89 mg (0. A methanol solution of 48 mmol) is heated under reflux for 2 hours. After cooling to room temperature, the solvent is evaporated under reduced pressure to give the title compound as a colorless powder. This product can be used in the next step without purification.

【0031】7.(2aR,3S,5aR,7S,8a
S,8bS)−3,7−ジメチル−2−メトキシ−2
a,3,5a,6,7,8,8a,8b−オクタヒドロ
−2H−ナフト−[1.8−bc]フランの合成 上記6.で得た(2aR,3S,5aR,7S,8a
S,8bS)−5−オキソ−2a,3,4,5,5a,
6,7,8,8a,8b−デカヒドロ−3,7−ジメチ
ル−2−メトキシ−2H−ナフト−[1.8−bc]フ
ラン p−トルエンスルホニルヒドラゾンの粗生成物全
量を無水THF5mlに溶解し、0℃で1.56M n
−ブチルリチウムヘキサン溶液2.6ml(4.0mm
ol)を滴下して加え、0℃でさらに2時間撹拌後反応
液を水に注ぎジエチルエーテルで抽出する。有機層を飽
和塩化アンモニウム水溶液及び飽和塩化ナトリウム水溶
液で洗浄後、無水硫酸ナトリウムで乾燥し溶媒を減圧留
去し表題化合物を無色油状物質として得る。このものは
精製することなく次工程に使用することができる。
7. (2aR, 3S, 5aR, 7S, 8a
S, 8bS) -3,7-Dimethyl-2-methoxy-2
Synthesis of a, 3,5a, 6,7,8,8a, 8b-octahydro-2H-naphtho- [1.8-bc] furan 6. (2aR, 3S, 5aR, 7S, 8a
S, 8bS) -5-oxo-2a, 3,4,5,5a,
The total amount of the crude product of 6,7,8,8a, 8b-decahydro-3,7-dimethyl-2-methoxy-2H-naphtho- [1.8-bc] furan p-toluenesulfonylhydrazone was dissolved in 5 ml of anhydrous THF. , 1.56M n at 0 ° C
-Butyl lithium hexane solution 2.6 ml (4.0 mm
ol) is added dropwise and the mixture is stirred at 0 ° C. for 2 hours, then the reaction solution is poured into water and extracted with diethyl ether. The organic layer is washed with saturated aqueous ammonium chloride solution and saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, and the solvent is evaporated under reduced pressure to give the title compound as a colorless oily substance. This product can be used in the next step without purification.

【0032】8.(2aR,3S,5aR,7S,8a
S,8bS)−2−オキソ−3,7−ジメチル−2a,
3,5a,6,7,8,8a,8b−オクタヒドロ−2
H−ナフト−[1.8−bc]フランの合成 上記7.で得た(2aR,3S,5aR,7S,8a
S,8bS)−3,7−ジメチル−2−メトキシ−2
a,3,5a,6,7,8,8a,8b−オクタヒドロ
−2H−ナフト−[1.8−bc]フランの粗生成物全
量をアセトン6mlに溶解し、0℃で2.67Mジョー
ンズ試薬2mlを加え2時間撹拌した後反応液にジエチ
ルエーテルを加え有機層を水、飽和炭酸水素ナトリウム
水溶液及び飽和塩化ナトリウム水溶液で順次洗浄後、無
水硫酸ナトリウムで乾燥し溶媒を減圧留去し得られた残
渣をシリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=2:1)で分離精製し表題化合物44mg
(6.よりの通算収率53%)を無色結晶として得る。
8. (2aR, 3S, 5aR, 7S, 8a
S, 8bS) -2-Oxo-3,7-dimethyl-2a,
3,5a, 6,7,8,8a, 8b-octahydro-2
Synthesis of H-naphtho- [1.8-bc] furan (2aR, 3S, 5aR, 7S, 8a
S, 8bS) -3,7-Dimethyl-2-methoxy-2
The total amount of the crude product of a, 3,5a, 6,7,8,8a, 8b-octahydro-2H-naphtho- [1.8-bc] furan was dissolved in 6 ml of acetone, and 2.67M Jones reagent was added at 0 ° C. After adding 2 ml and stirring for 2 hours, diethyl ether was added to the reaction solution and the organic layer was washed successively with water, a saturated sodium hydrogen carbonate aqueous solution and a saturated sodium chloride aqueous solution, and then dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography (hexane:
Separation and purification with ethyl acetate = 2: 1) gave the title compound 44 mg.
(53% total yield from 6.) is obtained as colorless crystals.

【0033】 融点 77.0−78.0℃(石油エーテル) [α]25 D+121.6°(c=2.0,クロロホル
ム)1 H−NMR(CDCl3,δ,ppm) 1.03(3H,d,J=6.7Hz),1.24(3
H,d,J=7.3Hz),1.48−1.69(3
H,m),1.78−1.96(3H,m),2.01
(1H,ddd,J=4.1Hz,7.2Hz,13.
7Hz),2.45(1H,dd,J=3.7Hz,
7.3Hz),2.52−2.56(1H,m),4.
66(1H,dt,J=4.3Hz,6.9Hz),
5.56(1H,dt,J=9.5Hz,2.4H
z),5.64(1H,dt,J=9.5Hz,2.3
Hz)13 C−NMR(CDCl3,δ,ppm) 21.825(q),23.024(q),24.66
5(d),26.868(d),29.304(d),
33.674(t),34.837(t),39.46
4(d),47.493(d),78.291(d),
131.243(d),133.055(d),17
9.459(s) IR(KBr,cm-1) 2960,1760,118
0,1150 質量スペクトル m/z 206(M+,6.6),161(58.9),105
(100) 元素分析値 C13182として 計算値 C,75.69;H,8.79 測定値 C,75.60;H,8.78
Melting point 77.0-78.0 ° C. (petroleum ether) [α] 25 D + 121.6 ° (c = 2.0, chloroform) 1 H-NMR (CDCl 3 , δ, ppm) 1.03 ( 3H, d, J = 6.7 Hz), 1.24 (3
H, d, J = 7.3 Hz), 1.48-1.69 (3
H, m), 1.78-1.96 (3H, m), 2.01
(1H, ddd, J = 4.1Hz, 7.2Hz, 13.
7Hz), 2.45 (1H, dd, J = 3.7Hz,
7.3 Hz), 2.52-2.56 (1 H, m), 4.
66 (1H, dt, J = 4.3Hz, 6.9Hz),
5.56 (1H, dt, J = 9.5Hz, 2.4H
z), 5.64 (1H, dt, J = 9.5Hz, 2.3)
Hz) 13 C-NMR (CDCl 3 , δ, ppm) 21.825 (q), 23.024 (q), 24.66
5 (d), 26.868 (d), 29.304 (d),
33.674 (t), 34.837 (t), 39.46
4 (d), 47.493 (d), 78.291 (d),
131.243 (d), 133.055 (d), 17
9.459 (s) IR (KBr, cm -1 ) 2960, 1760, 118
0,1150 Mass spectrum m / z 206 (M + , 6.6), 161 (58.9), 105
(100) Elemental analysis value Calculated value as C 13 H 18 O 2 C, 75.69; H, 8.79 Measured value C, 75.60; H, 8.78

【0034】[0034]

【発明の効果】本発明に係る製造法及び製造中間体は、
医薬等の中間体の製造法または製造中間体として有用で
ある。
The manufacturing method and manufacturing intermediate according to the present invention are
It is useful as a method for producing an intermediate such as a medicine or an intermediate for production.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】一般式[I] 【化1】 (式中R1は低級アルキル基又はアリール低級アルキル
基を示し、R2は低級アルキル基を示す)で表されるオ
クタヒドロナフタレン誘導体をヒドロボレーションして
一般式[II] 【化2】 (式中R1は低級アルキル基又はアリール低級アルキル
基を示し、R2は低級アルキル基を示す)で表されるc
is−デカリン誘導体とした後、これを酸化して一般式
[III] 【化3】 (式中R1は低級アルキル基又はアリール低級アルキル
基を示し、R2は低級アルキル基を示す)で表されるc
is−デカリン誘導体とし、これを一般式[IV] 【化4】 (式中R1は低級アルキル基又はアリール低級アルキル
基を示し、R2は低級アルキル基を示し、R3、R4及び
5は同一又は異なって低級アルキル基を示すか又は
3、R4がフェニル基でR5が低級アルキル基を示す)
で表されるエノールシリルエーテルに変換し、これを脱
ヒドロシリル化して一般式[V] 【化5】 (式中R1は低級アルキル基又はアリール低級アルキル
基を示し、R2は低級アルキル基を示す。)で表される
エノン化合物としてこれを共役付加反応に付し一般式
[VI] 【化6】 (式中R1は低級アルキル基又はアリール低級アルキル
基を示し、R2及びR6は同一又は異なって低級アルキル
基を示す)で表される化合物とした後、塩基によりエピ
化して一般式[VII] 【化7】 (式中R1は低級アルキル基又はアリール低級アルキル
基を示し、R2及びR6は同一又は異なって低級アルキル
基を示す)で表されるtrans−デカリン誘導体とし
て、これを一般式[VIII] 【化8】 (式中R1は低級アルキル基又はアリール低級アルキル
基を示し、R2及びR6は同一又は異なって低級アルキル
基を示し、Tsはp−トルエンスルホニル基を示す)で
表されるヒドラゾン誘導体に変換し、次いで強塩基の作
用により一般式[IX] 【化9】 (式中R1は低級アルキル基又はアリール低級アルキル
基を示し、R2及びR6は同一又は異なって低級アルキル
基を示す)で表されるテトラヒドロナフタリン誘導体と
した後、脱アセタール化及び酸化を行うことを特徴とす
る一般式[X] 【化10】 (式中R2及びR6は同一又は異なって低級アルキル基を
示す)で表される3環性ラクトン誘導体の製造法。
1. A compound represented by the general formula [I]: (Wherein R 1 represents a lower alkyl group or an aryl lower alkyl group, and R 2 represents a lower alkyl group), the octahydronaphthalene derivative represented by the general formula [II] (Wherein R 1 represents a lower alkyl group or an aryl lower alkyl group, and R 2 represents a lower alkyl group)
After being formed into an is-decalin derivative, it is oxidized to give a compound represented by the general formula [III]: (Wherein R 1 represents a lower alkyl group or an aryl lower alkyl group, and R 2 represents a lower alkyl group)
An is-decalin derivative, which is represented by the general formula [IV] (Wherein R 1 represents a lower alkyl group or an aryl lower alkyl group, R 2 represents a lower alkyl group, R 3 , R 4 and R 5 are the same or different and represent a lower alkyl group, or R 3 , R 4 4 is a phenyl group and R 5 is a lower alkyl group)
It is converted to an enol silyl ether represented by the formula, and this is dehydrosilylated to give a compound of the general formula [V] (In the formula, R 1 represents a lower alkyl group or an aryl lower alkyl group, and R 2 represents a lower alkyl group.) As an enone compound, the enone compound was subjected to a conjugate addition reaction to give a compound of the general formula [VI] ] (Wherein R 1 represents a lower alkyl group or an aryl lower alkyl group, and R 2 and R 6 are the same or different and represent a lower alkyl group) and then epi-ized with a base to give a compound of the general formula [ VII] (Wherein R 1 represents a lower alkyl group or an aryl lower alkyl group, and R 2 and R 6 are the same or different and represent a lower alkyl group), and the trans-decalin derivative is represented by the general formula [VIII] [Chemical 8] (Wherein R 1 represents a lower alkyl group or an aryl lower alkyl group, R 2 and R 6 are the same or different and represent a lower alkyl group, and Ts represents a p-toluenesulfonyl group). Conversion and then by the action of a strong base, a compound of the general formula [IX] (Wherein R 1 represents a lower alkyl group or an aryl lower alkyl group, and R 2 and R 6 are the same or different and represent a lower alkyl group), and then deacetalized and oxidized. General formula [X] characterized in that (Wherein R 2 and R 6 are the same or different and each represents a lower alkyl group).
【請求項2】一般式[IX] 【化11】 (式中R1は低級アルキル基又はアリール低級アルキル
基を示し、R2及びR6は同一又は異なって低級アルキル
基を示す)で表される一般式[X] 【化12】 (式中R2及びR6は同一又は異なって低級アルキル基を
示す)で表される3環性ラクトン誘導体の製造中間体。
2. The general formula [IX]: (Wherein R 1 represents a lower alkyl group or an aryl lower alkyl group, and R 2 and R 6 are the same or different and represent a lower alkyl group) [X] (In the formula, R 2 and R 6 are the same or different and each represents a lower alkyl group.) A production intermediate of a tricyclic lactone derivative.
JP16307694A 1994-06-02 1994-06-22 Production of tricyclic lactone compound Pending JPH0848678A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16307694A JPH0848678A (en) 1994-06-02 1994-06-22 Production of tricyclic lactone compound

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6-142207 1994-06-02
JP14220794 1994-06-02
JP16307694A JPH0848678A (en) 1994-06-02 1994-06-22 Production of tricyclic lactone compound

Publications (1)

Publication Number Publication Date
JPH0848678A true JPH0848678A (en) 1996-02-20

Family

ID=26474290

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16307694A Pending JPH0848678A (en) 1994-06-02 1994-06-22 Production of tricyclic lactone compound

Country Status (1)

Country Link
JP (1) JPH0848678A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3538090A4 (en) * 2016-11-09 2020-04-29 Purdue Research Foundation Tricyclic p2-ligand containing potent hiv-protease inhibitors against hiv/aids

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3538090A4 (en) * 2016-11-09 2020-04-29 Purdue Research Foundation Tricyclic p2-ligand containing potent hiv-protease inhibitors against hiv/aids
US11028096B2 (en) 2016-11-09 2021-06-08 Purdue Research Foundation Tricyclic P2-ligand containing potent HIV-protease inhibitors against HIV/AIDS
US11390630B2 (en) 2016-11-09 2022-07-19 Purdue Research Foundation Tricyclic P2-ligand containing potent HIV-protease inhibitors against HIV/AIDS

Similar Documents

Publication Publication Date Title
JP3030157B2 (en) Cyclohexanetriol derivative
Jacobi et al. Total synthesis of (.+-.)-gnididione and (.+-.)-isognididione
Toshimitsu et al. Pyridylseleno group in organic synthesis. Preparation and oxidation of. alpha.-(2-pyridylseleno) carbonyl compounds leading to. alpha.,. beta.-unsaturated ketones and aldehydes
Wakamatsu et al. Naturally occurring ten-membered lactones: total synthesis of (.+-.)-diplodialide A,(.+-.)-diplodialide C, and (.+-.)-decan-9-olide
Ando et al. Studies on the Synthesis of Sesquiterpene Lactones, 16. The Syntheses of 11β, 13-Dihydrokauniolide, Estafiatin, Isodehydrocostuslactone, 2-Oxodesoxyligustrin, Arborescin, 1, 10-Epiarborescin, 11β, 13-Dihydroludartin, 8-Deoxy-11β, 13-dihydrorupicolin B, 8-Deoxyrupicolin B, 3, 4-Epiludartin, Ludartin, Kauniolide, Dehydroleucodin, and Leucodin
Marshall et al. Synthesis of racemic globulol via solvolysis-cyclization of a 2, 7-cyclodecadien-1-ol derivative
US5120880A (en) Preparation of muscone, intermediates for this preparation and preparation of said intermediates
JPH0148272B2 (en)
Chiu et al. Synthesis of 15-deoxy-16. beta.-ethoxybruceantin and synthetic efforts toward bruceantin
Ziegler et al. Synthesis of the 1, 3-dioxolane ring system of the trichothecenes sambucinol and sporol via a stereoselective Claisen rearrangement
US4367340A (en) 4-Oxy-cyclopent-2-en-1-one derivative, a prostaglandin intermediate, and the process for its preparation
EP0024095B1 (en) Total synthesis of (1rs, 4sr, 5rs)-4-(4,8-dimethyl-5-hydroxy-7-nonenyl)-4-methyl-3,8-dioxabicyclo (3.2.1) octane-1-acetic acid and intermediates
JPH0848678A (en) Production of tricyclic lactone compound
Matsumoto et al. The synthesis of ar-abietatrien-12, 16-oxide and its C-15 epimer.
JPH047346B2 (en)
EP0039595B1 (en) Total synthesis of 1rs,4sr,5rs-4-(4,8-dimethyl-5-hydroxy-7-nonen-1-yl)-4-methyl-3,8-dioxabicyclo(3.2.1)octane-1-acetic acid and related compounds
JP2503073B2 (en) 2-Substituted-2-cyclopentenones and osteogenic promoters or anticancer agents containing the same
US4360467A (en) Process for preparing 8-oxabicyclo[3.2.1]-octane-1-acetic acids
JPH0753681B2 (en) Method for producing tropone derivative
JP2743797B2 (en) Preparation of optically active compounds
JP2785657B2 (en) Preparation of optically active compounds
JP4982917B2 (en) Process for producing optically active enone and intermediate
Tanimori et al. Synthesis of (±)-epiinvictolide
JPH0745504B2 (en) Prostaglandin precursor and process for producing the same
JP3097678B2 (en) Aphanorphin intermediate